EUVIMEDEUVIMED entdecken
Crossref

Protective effects of BTK inhibition by acalabrutinib on cisplatin-induced renal and testicular injury in mice: Modulation of mTOR/AMPK, NLRP3/GSDMD-N, and apoptotic pathways.

Sara H Hazem, Karim M Saad, Mahmoud M Samaha

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Sara H Hazem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt. Electronic address: sarahesham12@mans.edu.…. Hauptthemen laut MEDLINE: Agammaglobulinaemia Tyrosine Kinase, Testis, Benzamides, Kidney Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Faculty of Dentistry, Chulalongkorn University, Mansoura University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cisplatin-induced nephrotoxicity and testicular injury pose significant challenges during chemotherapy. AIM: The current study evaluates the efficacy of acalabrutinib (ACB), a Bruton's tyrosine kinase inhibitor, in mitigating cisplatin-induced damage in renal and testicular tissues in mice. METHODS: Testicular and renal toxicity was induced by a single I.P. injection of cisplatin (25 mg/kg). Mice were randomized into four groups: Normal (treated with vehicle), Cis (cisplatin + vehicle), Cis + ACB (6 mg/kg), and Cis + ACB (12 mg/kg). ACB was administered orally for three consecutive days, starting at Day 0 (1 h before single I.P. injection of cisplatin) and continued for Day 1 and Day 2. RESULTS: ACB treatment (6 mg/kg and 12 mg/kg) significantly improved renal function by reducing serum creatinine, BUN, and KIM-1 levels, while also attenuating inflammation and apoptosis, as evidenced by decreased NLRP3, CD68, and caspase-3 expression. Additionally, it mitigated molecular damage by downregulating mTOR, AMPK, and GSDMD-N. In testicular tissues, ACB preserved structure, restored spermatogenesis, and improved sperm viability and testosterone levels. The protective effects were associated with reduced inflammation, apoptosis, and pyroptosis, indicated by lower levels of cathepsin L, NLRP3, and GSDMD-N. CONCLUSIONS: These findings suggest that ACB offers a promising therapeutic approach to reduce the adverse effects of cisplatin, potentially enhancing the overall efficacy and safety of chemotherapy regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Agammaglobulinaemia Tyrosine KinaseTestisBenzamidesKidney DiseasesProtein Kinase InhibitorsAnimalsMaleCisplatinNLR Family, Pyrin Domain-Containing 3 ProteinMiceApoptosisTOR Serine-Threonine KinasesKidneyAMP-Activated Protein KinasesSignal TransductionAntineoplastic Agents

Stichwörter der Autor:innen

AcalabrutinibApoptosisBTK inhibitionCisplatinmTOR/AMPK

Substanzen

CisplatinNLR Family, Pyrin Domain-Containing 3 ProteinAgammaglobulinaemia Tyrosine KinaseTOR Serine-Threonine KinasesNlrp3 protein, mouseAMP-Activated Protein KinasesBenzamidesmTOR protein, mouseAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt. Electronic address: sarahesham12@mans.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt. Electronic address: Kareem_saad4@mans.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt. Electronic address: msamaha@mans.edu.eg.

Förderung

  • Faculty of Dentistry, Chulalongkorn University
  • Mansoura University

Zitieren

APA

Hazem, S. H., Saad, K. M., & Samaha, M. M. (2025). Protective effects of BTK inhibition by acalabrutinib on cisplatin-induced renal and testicular injury in mice: Modulation of mTOR/AMPK, NLRP3/GSDMD-N, and apoptotic pathways. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114256

Vancouver

Hazem SH, Saad KM, Samaha MM. Protective effects of BTK inhibition by acalabrutinib on cisplatin-induced renal and testicular injury in mice: Modulation of mTOR/AMPK, NLRP3/GSDMD-N, and apoptotic pathways. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114256

BibTeX
@article{Hazem2025,
  author = {Hazem, Sara H and Saad, Karim M and Samaha, Mahmoud M},
  title = {Protective effects of BTK inhibition by acalabrutinib on cisplatin-induced renal and testicular injury in mice: Modulation of mTOR/AMPK, NLRP3/GSDMD-N, and apoptotic pathways},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114256}
}
Kostenlos starten →